Skip to content

Based on Androgen Receptor Gene to Study the Mechanism of Spleen Deficiency Damp-Heat Syndrome Depression with Seborrheic Alopecia

Based on Androgen Receptor Gene to Study the Mechanism of Spleen Deficiency Damp-Heat Syndrome Depression with Seborrheic Alopecia

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039771
Enrollment
Unknown
Registered
2020-11-08
Start date
2020-11-20
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Sponsors

Tongde Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Comply with the diagnostic criteria for depressive episodes in the United States Diagnostic Statistical Methods for Mental Disorders (DSM-V); 2. Comply with the diagnostic criteria for seborrheic alopecia in "Chinese Clinical Dermatology"; 3. Comply with the TCM syndrome type of spleen deficiency and damp-heat Type; 4. Hamilton Depression Rating Scale (HAMD-17) score >= 17 points; 5. Aged 18-65 years (including people aged 18 and 65), gender, culture, economy, etc. are not limited; 6. The patient has a clear consciousness, and can cooperate with relevant treatment, testing and inspection, voluntarily sign an informed consent form and be able to comply with the research plan; 7. Have not taken disease-related drugs in the past week.

Exclusion criteria

Exclusion criteria: 1. Those with serious self-harm and suicidal tendencies; 2. Women who are breastfeeding, pregnant or may become pregnant during the study period; 3. Have serious heart, liver, kidney, blood, tumor, immunity, epilepsy and other major diseases, have other mental diseases, have brain organic diseases, and have serious History of dependence on tobacco, alcohol and other psychoactive drugs; 4. Other types of hair loss: such as hypothyroidism or hyperthyroidism, hypoparathyroid or pituitary hypofunction, hypogonadism and other endocrine alopecia.

Design outcomes

Primary

MeasureTime frame
Hamilton rating scale for depression;Hamilton Anxiety Scale;Dermatology Life Quality Index;Seborrheic Alopecia Questionnaire;

Countries

China

Contacts

Public ContactLanying Liu

Tongde Hospital of Zhejiang Province

balindaliu@163.com+86 13516816012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026